Cargando…

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers

AIM: To study the prognostic value of immunohistochemically detected low Claudin3 expression in breast cancers. METHODS: This retrospective study included patients with breast cancer who were investigated at our unit from 2006 to 2015. Tissue microarrays were constructed, and immunohistochemical sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mudduwa, Lakmini, Peiris, Harshini, Gunasekara, Shania, Abeysiriwardhana, Deepthika, Liyanage, Thusharie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802694/ https://www.ncbi.nlm.nih.gov/pubmed/29434471 http://dx.doi.org/10.1177/1178223417745858

Ejemplares similares

KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy
por: Mudduwa, Lakmini, et al.
Publicado: (2018)

Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
por: Mudduwa, Lakmini KB, et al.
Publicado: (2018)

Validity of St Gallen risk categories in prognostication of breast cancer patients in Southern Sri Lanka
por: Peiris, Harshini, et al.
Publicado: (2018)

The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer
por: Zhang, Yiqi, et al.
Publicado: (2020)

Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors
por: Stalker, Leanne, et al.
Publicado: (2014)

Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer
por: Kojima, Manabu, et al.
Publicado: (2020)

Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
por: Rädler, Patrick D., et al.
Publicado: (2021)

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
por: Sabatier, Renaud, et al.
Publicado: (2014)

Expression and significance of PTEN and Claudin-3 in prostate cancer
por: Ye, Xinglong, et al.
Publicado: (2019)

Prognostic Significance of Claudin 4 in Completely Resected Adenocarcinoma of the Lung
por: Chae, Min Cheol, et al.
Publicado: (2014)

Do Breast Cancer Risk Factors Affect the Survival of Breast Cancer Patients in Southern Sri Lanka?
por: Peiris, HH, et al.
Publicado: (2017)

Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
por: Widodo, Irianiwati, et al.
Publicado: (2018)

The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer
por: An, Xin, et al.
Publicado: (2018)

Comprehensive analysis of expression and prognostic value of the claudin family in human breast cancer
por: Yang, Guangda, et al.
Publicado: (2021)

Expression of claudin-5, claudin-7 and occludin in oral squamous cell carcinoma and their clinico-pathological significance
por: Phattarataratip, Ekarat, et al.
Publicado: (2016)

Research progress of Claudin-low breast cancer
por: Pan, Chenglong, et al.
Publicado: (2023)

Data set of the protein expression profiles of Luminal A, Claudin-low and overexpressing HER2(+) breast cancer cell lines by iTRAQ labelling and tandem mass spectrometry
por: Calderón-González, Karla Grisel, et al.
Publicado: (2015)

Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis
por: Liu, Jin-xin, et al.
Publicado: (2015)

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
por: Alsuliman, Abdullah, et al.
Publicado: (2015)

Expression and Clinical Significance of Claudin-7 in Patients With Colorectal Cancer
por: Xu, Chang, et al.
Publicado: (2018)

Clinical Significance of Claudin Expression in Oral Squamous Cell Carcinoma
por: Zejc, Tatjana, et al.
Publicado: (2022)

Barleria prionitis L. extracts ameliorate doxorubicin-induced acute kidney injury via modulation of oxidative stress, inflammation, and apoptosis
por: Amarasiri, Sachinthi S., et al.
Publicado: (2023)

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
por: Masisi, Brendah K., et al.
Publicado: (2021)

EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications
por: Voutsadakis, Ioannis A.
Publicado: (2023)

Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
por: Dias, Kay, et al.
Publicado: (2017)

Differential response to exercise in claudin-low breast cancer
por: Glass, Oliver K., et al.
Publicado: (2017)

Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer
por: KARABULUT, MEHMET, et al.
Publicado: (2015)

All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4
por: Shousha, Sami, et al.
Publicado: (2019)

Prognostic significance of claudin-1 and cyclin B1 protein expression in patients with hypopharyngeal squamous cell carcinoma
por: LI, WUJIE, et al.
Publicado: (2016)

Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer
por: Seo, Kyung Won, et al.
Publicado: (2010)

Prognostic value of claudin 18.2 expression in gastric adenocarcinoma
por: Kayikcioglu, Erkan, et al.
Publicado: (2023)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Clinicopathological significance of claudin-4 in gastric carcinoma
por: Zhu, Jin-Liang, et al.
Publicado: (2013)

Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis
por: Gao, Haiyan, et al.
Publicado: (2018)

Re-definition of claudin-low as a breast cancer phenotype
por: Fougner, Christian, et al.
Publicado: (2020)

Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells
por: Levine, Fayola, et al.
Publicado: (2021)

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

Claudins in intestines: Distribution and functional significance in health and diseases
por: Lu, Zhe, et al.
Publicado: (2013)

Analysis of the Potent Prognostic Factors in Luminal-Type Breast Cancer
por: Kim, Han-Sung, et al.
Publicado: (2012)

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
por: Prat, Aleix, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_g7tt03733rhanfl1jfpn5mrhbe